Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency

European Journal of Endocrinology

Volumn 166, Issue 2, 2012, Pages 181-189

  Elbornsson, Mariam ^a   Götherström, Galina ^a   Franco, Celina ^a   Bengtsson, Bengt Åke ^a   Johannsson, Gudmundur ^a   Svensson, Johan ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ADENOHYPOPHYSIS; ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; BONE DENSITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; TREATMENT DURATION; TREATMENT RESPONSE; WAIST HIP RATIO;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGING; BONE DENSITY; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; MALE; MIDDLE AGED; TIME FACTORS;

EID: 84856112452     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0886     Document Type: Article

References (34)

1. de Boer H, Blok GJ & Van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews 1995 16 63-86. (doi:10.1210/er.16.1.63)
2. Carroll PV, Christ ER, Bengtsson B-Å, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T & Thorner M. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. Journal of Clinical Endocrinology and Metabolism 1998 83 382-395. (doi:10.1210/jc.83.2.382)
3. Drake WM, Howell SJ, Monson JP & Shalet SM. Optimizing GH therapy in adults and children. Endocrine Reviews 2001 22 425-450. (doi:10.1210/er.22.4. 425)
4. Attanasio A, Lamberts S, Matranga A, Birkett M, Bates P, Valk N, Hilsted J, Bengtsson B-Å & Strasburger C. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Journal of Clinical Endocrinology and Metabolism 1997 82 82-88. (doi:10.1210/jc.82.1.82)
5. Koranyi J, Svensson J, Götherström G, Sunnerhagen K, Bengtsson B-Å & Johannsson G. Baseline characteristics and the effects of five years of growth hormone (GH) replacement therapy in adults with GH deficiency of childhood or adulthood onset; a comparative, prospective study. Journal of Clinical Endocrinology and Metabolism 2001 86 4693-4699. (doi:10.1210/jc.86.10. 4693)
6. Corpas E, Harman S & Blackman M. Human growth hormone and human aging. Endocrine Reviews 1993 14 20-38. (doi:10.1210/edrv-14-1-20)
7. Lamberts S, Van den Beld A & Van der Lely A-J. The endocrinology of aging. Science 1997 278 419-424. (doi:10.1126/science.278.5337.419)
8. Toogood A, O'Neill P & Shalet S. Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years. Journal of Clinical Endocrinology and Metabolism 1996 81 460-465. (doi:10.1210/jc.81.2.460)
9. Toogood A, Adams J, O'Neill P & Shalet S. Body composition in growth hormone deficient adults over the age of 60 years. Clinical Endocrinology 1996 45 399-405. (doi:10.1046/j.1365-2265.1996.8310842.x)
10. Monson J, Abs R, Bengtsson B-Å, Bennmarker H, Feldt- Rasmussen U, Hernberg-Stahl E, Thorén M, Westberg B, Wilton P & Wuster C. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database. Clinical Endocrinology 2000 53 281-289. (doi:10.1046/j.1365- 2265.2000.01104.x)
11. Elgzyri T, Castenfors J, Hagg E, Backman C, Thorén M & Bramnert M. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency. Clinical Endocrinology 2004 61 113-122. (doi:10.1111/j.1365-2265. 2004.02080.x)
12. Götherström G, Bengtsson B-Å, Sunnerhagen K, Johannsson G & Svensson J. The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary adults. Clinical Endocrinology 2005 62 105-113. (doi:10.1111/j.1365-2265.2004.02181.x)
13. Franco C, Johannson G, Bengtsson B-A° & Svensson J. Baseline charcteristics and effects of growth hormone therapy over two years in younger and older adults with adult onset GH deficiency. Journal of Clinical Endocrinology and Metabolism 2006 91 4408-4414. (doi:10.1210/jc.2006-0887)
14. Ohlsson C, Bengtsson B-Å, Isaksson O, Andreassen T & Slootweg M. Growth hormone and bone. Endocrine Reviews 1998 19 55-79. (doi:10.1210/er.19.1.55)
15. Götherström G, Svensson J, Koranyi J, Alpsten M, Bosaeus I, Bengtsson B-Å & Johannsson G. A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. Journal of Clinical Endocrinology and Metabolism 2001 86 4657-4665. (doi:10.1210/jc.86.10.4657)
16. Götherström G, Bengtsson B-Å, Bosaeus I, Johannsson G & Svensson J. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency. European Journal of Endocrinology 2007 156 55-64. (doi:10.1530/eje.1.02317)
17. Davidson P, Milne R, Chase D & Cooper C. Growth hormone replacement in adults and bone mineral density: a systematic review and meta-analysis. Clinical Endocrinology 2004 60 92-98. (doi:10.1111/j.1365-2265.2004.01935.x)
18. Hazem A, Elamin MB, Bancos I, Malaga G, Prutsky G, Domecq JP, Elraiyah TA, Abu Elnour NO, Prevost Y, Almandoz J, Zeballos-Palacios C, Velasquez R, Erwin PJ, Natt N, Montori VM & Murad MH. Body composition and quality of life in adults treated with growth hormone therapy: a systematic review and meta-analysis. European Journal of Endocrinology 2012 166 13-20. (doi:10.1530/EJE-11-0558)
19. Toogood A, Adams J, O'Neill P & Shalet S. Elderly patients with adult-onset growth hormone deficiency are not osteopenic. Journal of Clinical Endocrinology and Metabolism 1997 82 1462-1466. (doi:10.1210/jc.82.5.1462)
20. Fernholm R, Bramnert M, Hagg E, Hilding A, Baylink D, Mohan S & Thorén M. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease. Journal of Clinical Endocrinology and Metabolism 2000 85 4104-4112. (doi:10.1210/jc.85.11.4104)
21. Kokshoorn NE, Biermasz NR, Roelfsema F, Smit J, Pereira AM & Romijn JA. GH replacement therapy in elderly GH-deficient patients: a systematic review. European Journal of Endocrinology 2011 164 657-665. (doi:10.1530/EJE-10- 1170)
22. Johannsson G, Rosén T & Bengtsson B-Å. Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. Clinical Endocrinology 1997 47 571-581. (doi:10.1046/j.1365-2265.1997. 3271123.x)
23. Mazess R, Barden H, Bisek J & Hanson J. Dual-energy X-ray absorptiometry for total-body and and regional bone-mineral and soft-tissue composition. American Journal of Clinical Nutrition 1990 51 1106-1112.
24. Brabant G, Von Zur Mü hlen A, Wü ster C, Ranke M, Kratzsch J, Kiess W, Ketelslegers J-M, Wilhelmsen L, Hultén L, Saller B, Mattsson A, Wilde J, Schemer R & Kann P. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Hormone Research 2003 60 53-60. (doi:10.1159/000071871)
25. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosén T, Lindstedt G, Lundberg P-A & Bengtsson B-Å. Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clinical Endocrinology 1994 41 351-357. (doi:10.1111/j.1365-2265. 1994.tb02556.x)
26. Svensson J, Johannsson G & Bengtsson B-Å. Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test. Clinical Endocrinology 1997 46 579-586. (doi:10.1046/j.1365-2265.1997.1851001.x)
27. Feldt-Rasmussen U, Wilton P & Jonsson P. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults. Growth Hormone & IGF Research 2004 14 (Suppl A) S51-S58. (doi:10.1016/j.ghir.2004.03.013)
28. Johannsson G, Rosen T, Bosaeus I, Sjostrom L & Bengtsson B-Å. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. Journal of Clinical Endocrinology and Metabolism 1996 81 2865-2873. (doi:10.1210/jc.81.8. 2865)
29. Wüster C, Slenczka E & Ziegler R. Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: need for additional growth hormone substitution? Klinische Wochenschrift 1991 69 769-773. (doi:10.1007/BF01797616)
30. Rosén T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G & Bengtsson B-Å. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. European Journal of Endocrinology 1997 137 240-245. (doi:10.1530/eje.0.1370240)
31. Wüster C, Abs R, Bengtsson B-Å, Bennmarker H, Feldt- Rasmussen U, Hernberg-Stahl E, Monson J, Westberg B & Wilton P. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. Journal of Bone and Mineral Research 2001 16 398-405. (doi:10.1359/jbmr.2001.16.2.398)
32. Holmer H, Svensson J, Rylander L, Johannsson G, Rosén T, Bengtsson B-Å, Thorén M, Höybye C, Degerblad M, Bramnert M, Hägg E, Engström B, Ekman B, Thorngren K, Hagmar L & Erfurth E. Fracture incidence in GH-deficient patients on complete hormone replacement including GH. Journal of Bone and Mineral Research 2007 22 1842-1850. (doi:10.1359/jbmr. 070811)
33. Cummings S, Black D, Thompson D, Applegate W, Barrett- Connor E, Musliner T, Palermo L, Prineas R, Rubin S, Scott J, Vogt T, Wallace R, Yates A & LaCroix A. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. Journal of the American Medical Association 1998 280 2077-2082. (doi:10.1001/jama.280.24.2077)
34. GH Deficiency Consensus Workshop Participants. Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, LawsonWilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. European Journal of Endocrinology 2007 157 695-700. (doi:10.1530/EJE-07-0631)